NCT03911895

Brief Summary

Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

April 11, 2019

Status Verified

March 1, 2019

Enrollment Period

1 year

First QC Date

March 26, 2019

Last Update Submit

April 9, 2019

Conditions

Stable Chronic Angina

Outcome Measures

Primary Outcomes (1)

  • Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI

    to study effect of stent length in patients undergoing PCI

    3 months

Study Arms (1)

patients with coronary artery diseas undergoing PCI

Effect of stent length on patients with coronary artery undergoing PCI

Device: Stent more than 26 mn lengthDevice: Stent equal to or less than26 mn length

Interventions

Stent more than 26 mn lengthDEVICE

stent length in patients undergoing PCI (Drug Eluting Stent)

patients with coronary artery diseas undergoing PCI
Stent equal to or less than26 mn lengthDEVICE

stent length in patients undergoing PCI (Drug Eluting Stent)

patients with coronary artery diseas undergoing PCI

Eligibility Criteria

Age25 Years - 80 Years
Sexall(Gender-based eligibility)
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with stable coronary artery disease undergoing PCI

You may qualify if:

  • patient was CAD referred for elective PC as single vessel

You may not qualify if:

  • patients admitted ACS patients with primary PCI PTCA without stenting No complete revascularization PCI-related coronary complication (diessaction,no really)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed abdelbast

Asyut, 23123, Egypt

RECRUITING

MeSH Terms

Conditions

Angina, Stable

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Mohamed Donkol

CONTACT

+201002078279Mohameddonkol141291@gmail.com

Ahmed Abdel Galeel

CONTACT

+201005015156Ahmed_gelil@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 26, 2019

First Posted

April 11, 2019

Study Start

July 1, 2019

Primary Completion

June 30, 2020

Study Completion

September 30, 2020

Last Updated

April 11, 2019

Record last verified: 2019-03

Locations

EG(1)